An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral

Protein Cell. 2024 Jan 3;15(1):69-75. doi: 10.1093/procel/pwad033.

Miao Mei^{1

2}, Maria Antonietta Impagnatiello³, Jun Jiao^{1

2}, Ulrich Reiser³, Ulrike Tontsch-Grunt³, Ju Zhang⁴, Paul Nicklin⁵, Bingke Yu⁶, Yu Wang⁴, Yuan He⁶, Xu Tan^{1

2}

¹ Tsinghua-Peking Center for Life Sciences, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
² Chinese Institutes for Medical Research, Beijing 100069, China.
³ Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
⁴ College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
⁵ Research Beyond Borders, Boehringer Ingelheim, Biberach an der Riss, Germany.
⁶ Research Beyond Borders, Boehringer Ingelheim, Shanghai 200120, China.

No abstract available

MeSH terms